CN101768135B - Preparation method of 2-amino-5-trifluoromethyl thiazole - Google Patents
Preparation method of 2-amino-5-trifluoromethyl thiazole Download PDFInfo
- Publication number
- CN101768135B CN101768135B CN2010100225628A CN201010022562A CN101768135B CN 101768135 B CN101768135 B CN 101768135B CN 2010100225628 A CN2010100225628 A CN 2010100225628A CN 201010022562 A CN201010022562 A CN 201010022562A CN 101768135 B CN101768135 B CN 101768135B
- Authority
- CN
- China
- Prior art keywords
- water
- amino
- reaction
- compound method
- trifluoromethyl thiazole
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- DMGAMZGETZDLBL-UHFFFAOYSA-N Nc1ncc(C(F)(F)F)[s]1 Chemical compound Nc1ncc(C(F)(F)F)[s]1 DMGAMZGETZDLBL-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Thiazole And Isothizaole Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention relates to a preparation method of 2-amino-5-trifluoromethyl thiazole. A target product with a structural formula disclosed in the specification is prepared from 2-amino thiazole or a salt thereof through a one-step reaction with a yield of 30-85 percent. The method has simple and easily obtained reagent, moderate reaction condition, short time, simple operation, lower requirement on equipment, simple after treatment and practical production significance.
Description
Technical field
The present invention relates to the preparation method of 2-amino-5-trifluoromethyl thiazole.
Background technology
The thiazolamine compounds has wide biological activity, in medicine, agricultural chemicals, some commercial products has been arranged.
Belong to third generation cephalosporin like cefotaxime (Cefotaxime) in the medicine; The reason of this medicine wide spectrum is that the thiazolamine group in the molecule has increased the avidity of medicine and bacterium penicillin-binding protein; Like InComprehensive Heterocyclic Chemistry II; Katritzky, A.R, etc; Pergamon:Oxford, Vol.3, (1994).Sulphathiazole (ST) be used as very early antibacterials (US 2,491,489; FR 6,773).Nitazoxanide (Nitazoxanide) be used to treat the diarrhoea that courses of infection causes (US 5,387,598; DE2,438,037).Meloxicam (Meloxicam) is a kind of NSAIDs, and the activity that can selectivity suppresses cyclooxygenase-2 suppresses synthetic (US 4,233,299) of prostaglandin(PG).Ambilhar (Niridazole) is used as the medicine of treatment schistosomicide, referring to: American journal of veterinary research, Vol.34,641-645, (1973); DE 2,728, and 802).
Just there was the test of pesticide effectiveness report agricultural chemicals aspect, amicarthiazol (Amicarthiazol) before 1969, be toxicity such as low, the systemic fungicide of high-efficiency broad spectrum, and like Canadian Journal ofPlant Science, Vol.48,587-594, (1968).Guardian (Ethaboxam) is a systemic fungicide, is used to prevent and treat the downy mildew of garpe and the late blight of potato, but its mechanism of action is different from other sterilant of preventing and treating this type of disease, (EP639,574; DE 10,019, and 758; WO 2,000, and 018,766,2,001,084,930).By on can know; The thiazolamine compounds has good biological activity, and its biological activity of Basedol that different structure is modified is very different, so their target has variety probably; This helps delaying drug-fast development; Help the medicine guide's of new mechanism of action discovery, in a word, the structure activity study of thiazolamine compounds has very wide prospect.
Recently, 2-amino-5-trifluoromethyl thiazole receives increasing concern, contains this structure in many highly active molecules, and wherein representative example has: one type of glucokinase activators molecule, like WO2; 008,084,872,2,006; 078,621,2,004,081; 001,2,004,072,031; JP 2,008, and 189,659; One type of anti-HIV bioactive molecule is like Journal of Medicinal Chemistry, Vol.49,1118-1124, (2006); One type of anti-inflammatory activity molecule, as: Oxidation Communications, Vol.26,168-178, (2003); One type of calcium channel blocking agent molecule is like US 2,003,199,523; Herbicide intermediate is synthetic, like WO 9,637, and 466,9,533,719; One type of weedicide toxinicide molecule is like EP 335,831; One series bactericidal agent molecule is like US 5,135,927; One insecticides synthetic raw material is like DE 102,005,010,215.
Although this application of compound report increases gradually, about it synthetic report seldom.The Hantzsch synthesis method is classical thiazole compound method, but the raw material of Synthetic 2-amino-5-trifluoromethyl thiazole: and the preparation of 2-halogen-3-trifluoro propionic aldehyde does not have the yield report, is detected in EP 2,006,078,621.And react through 5 steps from Trifluoroacetic Acid Ethyl Ester, total recovery but is lower than 16%, as: Journal of Fluorine Chemistry.Vol.73,83-86; (1995), Chem.Leg.Vol.14,889, (1985), J.Chem.Soc; Perkin Trans.1,2761-2766, (1995).The route for preparing 2-amino-5-trifluoromethyl from 2-amino-5-carboxyl thiazole and sulfur tetrafluoride, hydrogen fluoride reaction is shown in WO 9,637,466, does not have the report of yield equally.
Compound method in sum, otherwise feedstock production is loaded down with trivial details, and productive rate is not high, or severe reaction conditions, and is higher to equipment requirements.Amino-5-trifluoromethyl thiazole cost is higher for the feasible a large amount of preparation 2-of these reasons, and safety-problems is outstanding.
Summary of the invention
The problem that the present invention need solve is to overcome above-mentioned defective, and the preparation method of a kind of 2-amino-5-trifluoromethyl thiazole compound is provided.
The structural formula of the 2-amino-5-trifluoromethyl thiazole that the present invention relates to is shown in (I):
The inventive method can use following reactions step synthetic:
CF in the formula
3X can be CF
3Cl, CF
3Br or CF
3I recommends CF
3Br or CF
3I.Reaction can be carried out under the condition of various radical initiators, like vat powder, rongalite, thiourea peroxide, Sodium Metabisulfite, sodium sulfite anhy 96 or their mixture; The mineral alkali that can add suitable monovalence metal; As yellow soda ash, sodium hydrogencarbonate, salt of wormwood, saleratus, sodium phosphate, Sodium phosphate, dibasic, potassiumphosphate and or potassium hydrogenphosphate etc.; Also can be organic basess such as triethylamine, pyridine, reaction also can be carried out under the condition that does not add alkali.The salt of described thiazolamine or its respective acids, trifluoro haloalkane, radical initiator and alkali mol ratio are 1.0: 2.0～4.0: 1.0～3.0: 0～3; Be reflected in the mixed solvent of organic solvent and water and carry out, like the acetonitrile-water mixed solvent; N-water; Halogenated hydrocarbon solvent-water such as methylene dichloride, ethylene dichloride or chloroform; DMSO 99.8MIN.-water; Ethers-water such as dioxane or THF; Ketone-water such as acetone or mibk; Methyl alcohol, the mixed solvent of alcohols-water such as ethanol or Virahol; It also can be the mixture of above-mentioned solvent.The optimum solvent of this reaction is the acetonitrile-water mixed solvent.Temperature of reaction is 0～90 ℃, and the reaction times is 3-8 hour.Adopt CF as working as
3During I, temperature of reaction is that zero degree arrives room temperature, perhaps is heated to 60 ℃, and reaction can be carried out in autoclave; When being CF
3During Br, temperature of reaction is 40～90 ℃, and reaction also can be carried out in autoclave.The molar ratio of thiazolamine, trifluoro haloalkane and radical initiator is recommended as 1.0: 2.0～and 4.0: 2.0.Final product can or be made other salt such as hydrochloride through silica gel column chromatography, underpressure distillation and be further purified.
Method reaction conditions of the present invention is gentle, and the time is short, simple to operate, lower to the requirement of equipment, aftertreatment is simple, and the reagent that is adopted is simple and easy to, and has the meaning of actual production.
Embodiment
Following examples help to understand the present invention, but the present invention not merely is confined in the scope of following embodiment.
Embodiment 1
In the 2L autoclave, add 40g thiazolamine, 160g vat powder, 100g Sodium phosphate, dibasic, 1.2 liters of acetonitriles, 400 ml waters; Sealing is the equipment mechanical stirring device also, autoclave is refrigerated to-78 ℃, vacuumizes, and with bromotrifluoromethane displaced air three times, vacuumizes; Be pressed into the 180g bromotrifluoromethane, after waiting to recover room temperature, be heated to 90 ℃ of reactions 6 hours, stop to stir, be chilled to room temperature; Vacuum is revolved most of acetonitrile, and it is 8-10 that the sodium hydroxide saturated aqueous solution is regulated aqueous pH values, extracted with diethyl ether, anhydrous magnesium sulfate drying; Concentrate the back column chromatography, (normal hexane: ETHYLE ACETATE=4: 1), get the light yellow thick liquid of pure article, yield 75%.
Embodiment 2
In the 1L autoclave, add 20g thiazolamine, 52.5g vat powder, 56.3g sodium hydrogencarbonate, 500 milliliters of acetonitriles, 200 ml waters; Sealing and equipment mechanical stirring device are refrigerated to autoclave-78 ℃, vacuumize, and are pressed into the 100g bromotrifluoromethane; After waiting to recover room temperature, be heated to 40 ℃ of reactions 6 hours, stop to stir, be chilled to room temperature; Vacuum is revolved most of acetonitrile, and it is 8-10 that the sodium hydroxide saturated aqueous solution is regulated aqueous pH values, extracted with diethyl ether, anhydrous magnesium sulfate drying; Concentrate the back column chromatography, (normal hexane: ETHYLE ACETATE=4: 1), get the light yellow thick liquid of pure article, yield 60%.
Embodiment 3
In 250ml Schlenk pipe, add the 3g thiazolamine, the 1.9g sodium hydrogencarbonate is substituted gas three times, and the Ar protection adds 50 milliliters of acetonitriles down, 50 milliliters of Ns, and 20 ml waters stir and make the solid dissolving.Then reaction solution is put into ice-water bath, be chilled to 3 ℃, 10 milliliters of acetonitrile solutions that add the 4g CF3I stirred two minutes.Add the 3.58g vat powder in half a hour in batches, stirred 2 hours, thin layer is analysed and is followed the tracks of reaction, and the back decompression that finishes revolves acetonitrile; Add appropriate amount of deionized water, sodium carbonate regulating solution is an alkalescence, and 300 milliliters of ether divide three extractions; Anhydrous magnesium sulfate drying, concentrate the orange-yellow liquid of thickness, column chromatography; (normal hexane: ETHYLE ACETATE=4: 1), get the light yellow thick liquid of pure article, yield 85%.
Embodiment 4
In 250ml Schlenk pipe, add the 3g thiazolamine, substitute gas three times, the Ar protection adds 50 milliliters of acetonitriles down, 50 milliliters of Ns, and 20 ml waters stir and make the solid dissolving.Then reaction solution is put into ice-water bath, be chilled to 3 ℃, add 10 milliliters of acetonitrile solutions of 4g CF3I, stirred two minutes.Add the 3.58g vat powder in half a hour in batches, stirred 2.5 hours, thin layer is analysed and is followed the tracks of reaction, and the back decompression that finishes revolves acetonitrile; Add appropriate amount of deionized water, sodium carbonate regulating solution is an alkalescence, and 300 milliliters of ether divide three extractions; Anhydrous magnesium sulfate drying, concentrate the orange-yellow liquid of thickness, column chromatography; (normal hexane: ETHYLE ACETATE=4: 1), get the light yellow thick liquid of pure article, yield 55%.
Embodiment 5
In 100ml Schlenk pipe, add the 0.5g thiazolamine, substitute gas three times, the Ar protection adds 30 milliliters of acetonitriles down, and 15 ml waters stir and make the solid dissolving.Then reaction solution is put into ice-water bath, be chilled to 3 ℃, add 5 milliliters of acetonitrile solutions of 0.7g CF3I, triethylamine 1.1g stirred two minutes.Add the 0.6g vat powder, stirred 2.5 hours, thin layer is analysed and is followed the tracks of reaction, and the back decompression that finishes revolves acetonitrile; Add appropriate amount of deionized water, sodium carbonate regulating solution is an alkalescence, and 300 milliliters of ether divide three extractions, washing (10 milliliters * 3); Anhydrous magnesium sulfate drying, concentrate the orange-yellow liquid of thickness, column chromatography; (normal hexane: ETHYLE ACETATE=4: 1), get the light yellow thick liquid of pure article, yield 42%.
Embodiment 6
In the 1L autoclave, add 20g thiazolamine, 53.0g vat powder, 400 milliliters of acetonitriles, 150 ml waters; Sealing and equipment mechanical stirring device are refrigerated to autoclave-78 ℃, vacuumize, and are pressed into the 120g bromotrifluoromethane; After waiting to recover room temperature, be heated to 90 ℃ of reactions 6 hours, stop to stir, be chilled to room temperature; Vacuum is revolved most of acetonitrile, and it is 8-10 that the sodium hydroxide saturated aqueous solution is regulated aqueous pH values, extracted with diethyl ether, anhydrous magnesium sulfate drying; Concentrate the back column chromatography, (normal hexane: ETHYLE ACETATE=4: 1), get the light yellow thick liquid of pure article, yield 30%.
Embodiment 7
In the 1L autoclave, add 20g thiazolamine, 53.0g vat powder, 4.0g triethylamine, 400 milliliters of acetonitriles, 150 ml waters; Sealing and equipment mechanical stirring device are refrigerated to autoclave-78 ℃, vacuumize, and are pressed into the 120g bromotrifluoromethane; After waiting to recover room temperature, be heated to 90 ℃ of reactions 6 hours, stop to stir, be chilled to room temperature; Vacuum is revolved most of acetonitrile, and it is 8-10 that the sodium hydroxide saturated aqueous solution is regulated aqueous pH values, extracted with diethyl ether, anhydrous magnesium sulfate drying; Concentrate the back column chromatography, (normal hexane: ETHYLE ACETATE=4: 1), get the light yellow thick liquid of pure article, yield 58%.
Embodiment 8
In 250ml Schlenk pipe, add the 3g thiazolamine, the 8.5g Sodium phosphate, dibasic is substituted gas three times, and the Ar protection adds 50 milliliters of acetonitriles down, 50 milliliters of Ns, and 20 ml waters stir and make the solid dissolving.Then reaction solution is put into ice-water bath, be chilled to 3 ℃, add 10 milliliters of acetonitrile solutions of 4g CF3I, stirred two minutes.Add the 3.58g vat powder in half a hour in batches, stirred 2 hours, thin layer is analysed and is followed the tracks of reaction, and the back decompression that finishes revolves acetonitrile; Add appropriate amount of deionized water, sodium carbonate regulating solution is an alkalescence, and 300 milliliters of ether divide three extractions; Anhydrous magnesium sulfate drying, concentrate the orange-yellow liquid of thickness, column chromatography; (normal hexane: ETHYLE ACETATE=4: 1), get the light yellow thick liquid of pure article, yield 83%.
Claims (6)
1. the compound method of 2-amino-5-trifluoromethyl thiazole, it is characterized in that in the mixed solvent of organic solvent and water, 0～90 ℃, exist or do not have under the condition of alkali thiazolamine, CF
3X trifluoro haloalkane and radical initiator reaction 3-8 hour; Described thiazolamine, trifluoro haloalkane, radical initiator and alkali mol ratio are 1.0: 2.0～4.0: 1.0～3.0: 0～3; Described radical initiator is vat powder, rongalite or thiourea peroxide, Sodium Metabisulfite, sodium sulfite anhy 96 or their mixture; Described CF
3X is Cl, Br or I among the X; Described alkali is the mineral alkali and the organic bases of monovalence metal.
2. the compound method of 2-amino as claimed in claim 1-5-trifluoromethyl thiazole, the mineral alkali that it is characterized in that described monovalence metal is yellow soda ash, sodium hydrogencarbonate, salt of wormwood, saleratus, sodium phosphate, Sodium phosphate, dibasic, potassiumphosphate or potassium hydrogenphosphate; Described organic bases is triethylamine or pyridine.
3. the compound method of 2-amino as claimed in claim 1-5-trifluoromethyl thiazole, the mixed solvent that it is characterized in that described organic solvent and water is an acetonitrile-water; N-water; Halogenated hydrocarbon-water; DMSO 99.8MIN.-water; Ethers-water; Ketone-water; The mixture of alcohols-water or above-mentioned solvent.
4. the compound method of 2-amino as claimed in claim 1-5-trifluoromethyl thiazole, when it is characterized in that described bromotrifluoromethane is raw material, temperature of reaction is 40-90 ℃.
5. the compound method of 2-amino as claimed in claim 1-5-trifluoromethyl thiazole is characterized in that; When described trifluoro haloalkane was CF3I, temperature of reaction was that zero degree arrives room temperature.
6. the compound method of 2-amino as claimed in claim 1-5-trifluoromethyl thiazole is characterized in that reaction product carries out purifying through silica gel column chromatography or underpressure distillation.
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010100225628A CN101768135B (en) | 2010-01-08 | 2010-01-08 | Preparation method of 2-amino-5-trifluoromethyl thiazole |
| PCT/CN2011/000036 WO2011082660A1 (en) | 2010-01-08 | 2011-01-07 | 5-multifluoroalkyl- substituted 2-aminothiazole compounds, preparation methods and uses thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010100225628A CN101768135B (en) | 2010-01-08 | 2010-01-08 | Preparation method of 2-amino-5-trifluoromethyl thiazole |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101768135A CN101768135A (en) | 2010-07-07 |
| CN101768135B true CN101768135B (en) | 2012-07-11 |
Family
ID=42501256
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2010100225628A Expired - Fee Related CN101768135B (en) | 2010-01-08 | 2010-01-08 | Preparation method of 2-amino-5-trifluoromethyl thiazole |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101768135B (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102993117A (en) * | 2012-11-28 | 2013-03-27 | 张家港市大伟助剂有限公司 | Preparation method of 2-amino-5-(4-amino phenyl)-thiazole |
-
2010
- 2010-01-08 CN CN2010100225628A patent/CN101768135B/en not_active Expired - Fee Related
Non-Patent Citations (1)
| Title |
|---|
| Frédéric Laduron， et al..α- or β-Trifluoromethyl epoxysulfones: new C3 reagents for heterocyclisation.《Journal of Fluorine Chemistry》.1995,第73卷第83-86页. * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101768135A (en) | 2010-07-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2945621B1 (en) | Pharmaceutical compositions comprising nitroxyl donors | |
| CN104610166B (en) | Pyrimidine benzyl hydroxamic acid histone deacetylases inhibitor and preparation method and application | |
| NO159660B (en) | ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTICALLY EFFECTIVE BIS-ESTERS OF METANTHIOL WITH ACETONIDES OF AMPICILLINOG PENICILLANIC ACID-1,1-DIOXYD. | |
| NO147598B (en) | ANALOGUE PROCEDURE FOR PREPARING NEW PHYSIOLOGICALLY ACTIVE FLUORACYL RESORCINOLS | |
| CN109988132B (en) | Preparation method of amiodarone hydrochloride | |
| CN108863964A (en) | Sulphonyl azole compounds of isopropanol bridging and its preparation method and application | |
| CN101768135B (en) | Preparation method of 2-amino-5-trifluoromethyl thiazole | |
| CN108358868A (en) | 2- replaces the novel processing step of benzothiazole compound | |
| CN101274921B (en) | Synthetic method for taurolidine and pharmaceutical preparations | |
| TWI636782B (en) | (+)-5-(3,4-difluorphenyl)-5-{(3-methyl-2-oxopyridine-1(2h)-yl)methyl}imidazolidine-2,4-dione and pharmaceuticals containing the same | |
| CN103724292A (en) | N-alcoxyl (sulfur) alkyl benzoheterocycle derivative and application thereof | |
| CN108863909A (en) | A kind of novel halogen amine structure compound and preparation method thereof and the application of antibacterial field | |
| CN101885708B (en) | 5-polyfluoroalkyl group substituted 2-aminothiazole compound, synthesis method and application thereof | |
| CN106632133A (en) | Novel thiazole derivatives, and preparation method and application thereof | |
| CN102807517A (en) | Synthesis of garlicin derivatives and preparation method for medical ultrasonic couplant with efficient disinfection function using garlicin derivatives | |
| US20190084957A1 (en) | 4-sulfur pentafluoride phenol compound and preparation method therefor, and preparation method for sulfur pentafluoride substituted benzopyran compound | |
| CN106565624B (en) | 9- azepine -1,11- undecalactone compound and its preparation and application containing substituent group | |
| CN104530029A (en) | Heterocyclic compounds as factor Xa inhibitors as well as using methods and application of heterocyclic compounds | |
| CN109232543A (en) | A kind of fungicide and its application | |
| CN104418834B (en) | A kind of synthetic method of antidiabetic medicine intermediate | |
| CN105439979B (en) | Benzoyl hydazone derivative containing 1,2,3 thiadiazoles and preparation method and application | |
| CN109081774A (en) | The preparation method of a plant ketone | |
| CN112225700B (en) | Preparation method of atemezole | |
| CN117343067A (en) | Continuous flow production process of antiviral agent TZV | |
| CN102260276A (en) | Prasugrel citrate and its preparation method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20120711 Termination date: 20180108 |